Aspida Re's primer lands as offshore cessions near $1T

Royal Gazette Bermuda Re reports that Aspida Life Re Ltd has published a white paper that tries to make offshore reinsurance legible to the professionals who buy it. Titled Demystifying Offshore Reinsurance: Nine Things Every Insurance Professional Should Know, the paper walks through reinsurance fundamentals, the differences between onshore and offshore structures, how deals are typically arranged, and what to look for in a partner. Aspida bills it as a plain-English primer for a market it says has outrun common understanding.

Since 2016, the amount of US life and annuity insurance ceded offshore has risen by nearly $1 trillion, and offshore reserves have come close to matching those held onshore, according to Aspida. The company lists capital efficiency, pricing competitiveness, and balance sheet flexibility as the strategic benefits, while acknowledging the risk-management trade-offs insurers should weigh. David Florian, Aspida Re's chief executive, said in a statement that offshore reinsurance "has become an essential component of the modern life and annuity industry, yet it's often misunderstood" and that the paper is meant to separate fact from fiction.

The white paper also spends time on the things that don't surface in a product pitch: common misconceptions about offshore structures, the key risks and trade-offs insurers should consider, and practical guidance for evaluating potential reinsurance partners. It makes the point that offshore reinsurance has evolved into a well-established component of the global life and annuity market, one that depends on strong regulatory oversight and governance. In Florian's words, "Today's offshore reinsurance market is far more sophisticated than many people realise."

The most telling line in the announcement is the one about policyholder protections, because offshore reinsurance has moved from a niche product to a mainstay of insurers' capital management. When offshore reserves approach parity with onshore books, the growth story is already priced; what still needs proving is whether the collateral behind those reserves is strong enough to honor the balance-sheet flexibility Aspida is selling. As this publication has argued, the collateral gap in offshore annuity reinsurance is where product build-out meets its balance-sheet limit. A primer can explain the structure, but it cannot substitute for reading the actual collateral agreements. Whether that collateral is trapped, investment-grade, or running down in line with the liabilities is the underwriting question that determines whether the flexibility is real.

That makes the white paper useful for a different reason than the one intended: it is a map of how the market wants to be seen. The familiar claims — strong regulatory oversight, sound governance, financially strong partners with aligned investment capabilities — are the words ceding insurers want to hear. The next test is whether the volume of offshore cessions is matched by the quality of the collateral behind them, and that is a balance-sheet test, not an education problem.